HPV vaccine has not been withdrawn in any country.
The Danish Health Authority has recommended HPV vaccine for girls as part of the national childhood immunisation programme since 2009.
The HPV vaccine used in Denmark is changing from Cervarix to Gardasil9 in November 2017 following a commercial tender process.
Gardasil9 protects from HPV types that are responsible for almost 90% of cervical cancers.
The Japanese government stopped active recommendation of HPV vaccination but has never banned the HPV vaccines.
Gardasil is still available in Japan.
In July 2017 the World Health Organization(WHO) reported the mortality rate from cervical cancer in Japan, where HPV vaccination is not proactively recommended, increased by 3.4% from 1995 to 2005 and is expected to increase by 5.9% from 2005 to 2015.
WHO Global Advisory Committee on Vaccine Safety (GACVS) Safety Update on HPV vaccines http://www.who.int/vaccine_safety/committee/topics/hpv/June_2017/en/
The Japanese Society of Obstetrics and Gynecology (JSOG) continues to actively campaign for the resumption of recommendations for HPV vaccination given the high rates of cervical cancer deaths in Japan.
Declaration to Demand the Resumption of Recommendations for Human Papillomavirus (HPV) Vaccination for Cervical Cancer Prevention available at http://www.jsog.or.jp/english/declaration_20150829.html
Article about HPV vaccine and Japan from The Lancet Medical Journal at - http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(15)61152-7.pdf
In 2010 the Indian Council of Medical Research suspended the HPV vaccine programme following unofficial reports of serious adverse reactions. Despite this the HPV vaccine remained available in India and continued to be endorsed by other advisory committees.
In March 2016 the Delhi government launched a HPV vaccine schools programme for girls.